Cancers,
Год журнала:
2024,
Номер
17(1), С. 54 - 54
Опубликована: Дек. 27, 2024
From
a
cancer-centric
perspective,
radiotherapy
has
been
primarily
viewed
as
localised
treatment
modality,
targeting
cancer
tissues
with
ionising
radiation
to
induce
DNA
damage
and
cell
death
[...]
Frontiers in Oncology,
Год журнала:
2024,
Номер
14
Опубликована: Фев. 12, 2024
Background
Neoadjuvant
radiotherapy
(neo-RT)
is
widely
used
in
locally
advanced
rectal
cancer
(LARC)
as
a
component
of
radical
treatment.
Despite
the
advantages
neo-RT,
which
typically
improves
outcomes
LARC
patients,
lack
reliable
biomarkers
that
predict
response
and
monitor
efficacy
therapy,
can
result
application
unnecessary
aggressive
therapy
affecting
patients’
quality
life.
Hence,
search
for
molecular
assessing
radio
responsiveness
this
represents
relevant
issue.
Methods
Here,
we
combined
proteomic
metabolomic
approaches
to
identify
signatures,
could
discriminate
tumors
with
good
poor
responses
neo-RT.
Results
The
integration
data
on
differentially
accumulated
proteins
metabolites
made
it
possible
disrupted
metabolic
pathways
signaling
processes
connected
irradiation,
including
ketone
bodies
synthesis
degradation,
purine
metabolism,
energy
degradation
fatty
acid,
amino
acid
focal
adhesion.
Moreover,
proposed
multi-component
panels
serve
solid
base
develop
monitoring
predicting
preoperative
RT
patients.
Conclusion
We
proved
an
integrated
multi-omic
approach
presents
valid
look
at
analysis
global
treatment
from
perspective
reprogramming.
Pharmaceuticals,
Год журнала:
2024,
Номер
17(6), С. 744 - 744
Опубликована: Июнь 6, 2024
Rarely
has
a
chemical
elicited
as
much
controversy
dichloroacetate
(DCA).
DCA
was
initially
considered
dangerous
toxic
industrial
waste
product,
then
potential
treatment
for
lactic
acidosis.
However,
the
main
controversies
started
in
2008
when
found
to
have
anti-cancer
effects
on
experimental
animals.
These
publications
showed
contradictory
results
vivo
and
vitro
such
that
thorough
consideration
of
this
compound’s
cancer
is
merited.
Despite
50
years
experimentation,
DCA’s
future
therapeutics
uncertain.
Without
adequate
clinical
trials
health
authorities’
approval,
been
introduced
off-label
treatments
alternative
medicine
clinics
Canada,
Germany,
other
European
countries.
The
lack
well-planned
its
use
by
people
without
medical
training
discouraged
scientific
community.
There
are
few
studies
DCA,
many
individual
case
reports.
Case
reports
benefits
against
increasing
recently.
Furthermore,
it
shown
synergizes
with
conventional
repurposable
drugs.
Beyond
classic
target,
pyruvate
dehydrogenase
kinase,
new
target
molecules
also
recently
discovered.
findings
renewed
interest
DCA.
This
paper
explores
whether
existing
evidence
justifies
further
research
role
may
play
it.
International Journal of Radiation Biology,
Год журнала:
2025,
Номер
unknown, С. 1 - 12
Опубликована: Янв. 10, 2025
Purpose
Breast
cancer
ranks
as
the
most
prevalent
in
women,
characterized
by
heightened
fatty
acid
synthesis
and
glycolytic
activity.
Fatty
synthase
(FASN)
is
prominently
expressed
breast
cells,
regulating
synthesis,
thereby
enhancing
tumor
growth
migration,
leading
to
radioresistance.
This
study
aims
investigate
how
FASN
inhibition
affects
cell
proliferation,
radioresistance
cancer,
well
mechanisms
involved.
Research Square (Research Square),
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 6, 2025
Abstract
Despite
initial
efficacy
of
radiotherapy
(RT),
with
or
without
concurrent
androgen-deprivation,
in
prostate
adenocarcinoma
(PCa),
neuroendocrine
cancer
(NEPC)
emerging
from
disease
progression
is
a
highly
aggressive
malignancy
for
which
standard
therapies
are
mostly
ineffective.
Although
oncogenic
MUC1-C
leading
driver
NEPC
and
PCa
lineage
plasticity,
its
putative
role
response
to
RT,
including
RT-induced
transdifferentiation
(tNED),
has
not
been
explored.
We
thus
aimed
explore
the
interplay
between
androgen
receptor
(AR)
signaling
MUC1
NEPC.
Firstly,
using
radioresistant
cell
line
(22Rv1-RR)
we
demonstrated
that
epigenetic
suppression
AR
caused
MUC1/MUC1-C
upregulation,
seems
be
activated
through
γSTAT3.
activation
positively
associated
increased
expression
neuroendocrine-related
markers,
CD56,
chromogranin
A,
synaptophysin
INSM
transcriptional
repressor
1
(INSM1).
In
tissues
comparing
adenocarcinoma,
was
upregulated
negatively
correlated
AR,
suppressed.
Finally,
proteomic
analyses
revealed
upon
RT
selective
pressure
led
acquisition
stemness
features,
induction
epithelial
mesenchymal
transition,
enhancement
basal
cell-like
traits.
Notably,
knockdown
(KD)
significantly
boosted
both
22Rv1-RR
DU145
lines.
Moreover,
AR-induced
overexpression
PC3
lines
entailed
downregulation,
resulting
attenuated
(NE)
traits
radioresistance,
as
well
impaired
migration
invasion
capabilities.
Collectively,
these
results
highlight
promising
radiosensitization
target
may
ultimately
help
overcome
therapy
resistance
progression.
Journal of Biochemical and Molecular Toxicology,
Год журнала:
2025,
Номер
39(3)
Опубликована: Фев. 23, 2025
ABSTRACT
Radiotherapy
is
a
cornerstone
of
lung
cancer
management,
though
its
efficacy
frequently
undermined
by
intrinsic
and
acquired
radioresistance.
This
review
examines
the
complexity
tumors,
highlighting
their
potential
as
reservoir
novel
targets
for
radiosensitization.
Ionizing
radiation
(IR)
primarily
exerts
effects
through
oxidative
damage
DNA
double‐strand
breaks
(DSBs).
Lung
cells,
however,
develop
mutations
that
enhance
response
(DDR)
suppress
cell
death
pathways.
Additionally,
interactions
between
tumor
cells
microenvironment
(TME)
components—including
immune
stromal
molecular
mediators
such
cytokines,
chemokines,
growth
factors—contribute
to
resistance
against
IR.
Understanding
these
intricate
relationships
reveals
improve
radiotherapy
outcomes.
Promising
include
DDR
pathways,
immunosuppressive
molecules,
hypoxia,
proangiogenic
mediators,
other
key
signaling
discusses
emerging
strategies,
combining
with
immunomodulators,
hypoxia
inhibitors,
DDR‐targeting
agents,
innovative
approaches.
By
offering
comprehensive
analysis
TME,
this
underscores
opportunities
effectiveness
targeted
radiosensitization
strategies.
Experimental Dermatology,
Год журнала:
2025,
Номер
34(3)
Опубликована: Март 1, 2025
ABSTRACT
Keloid
is
characterised
by
the
reprogramming
of
cellular
metabolism,
wherein
keloid
cells
adapt
their
metabolic
pathways
to
meet
demands
for
energy
and
biosynthetic
precursors.
Investigating
intricate
relationship
between
metabolism
biological
behaviour
holds
potential
yield
novel
therapeutic
strategies
keloid.
To
elucidate
molecular
alterations
underlying
regulatory
mechanisms
in
keloids,
we
created
comprehensive
profiling
at
pathway
level
analysing
metabolomic,
transcriptomic
single‐cell
RNA‐sequencing
data
from
keloids
adjacent
skin.
Viability
assay
clonogenic
were
performed
validate
function
pathway(s)
primary
fibroblast
cells.
Integrated
analysis
revealed
an
upregulation
arginine
proline
keloids.
According
RNA‐seq
data,
elevated
expression
genes
related
such
as
P4HA3,
P4HA2,
P4HA1,
PYCR1,
OAT
ASS1
,
was
predominately
highly
expressed
fibroblast‐2.
Fibroblast‐2
displayed
more
obvious
phenotypes
mesenchymal
fibroblast.
Critical
integrated
including
PYCR1
AZIN2
metabolites
fumaric
acid
2‐oxo‐5‐amino‐pentanoic
showed
prognostic
relevance
with
disease‐free
survival
Additionally,
In
vitro
study
that
deprivation
therapy
(ADT)
inhibited
radiosensitised
proliferation
keloid‐derived
fibroblasts.
conclusion,
our
thorough
multiomics
deepens
understanding
link
radiosensitivity.
Elevated
activity
fibroblasts
may
be
a
Rice Science,
Год журнала:
2024,
Номер
31(4), С. 449 - 462
Опубликована: Апрель 12, 2024
Tissue
culture
techniques
were
used
to
produce
large
amounts
of
bioactive
compounds
with
medicinal
potential,
overcoming
space
and
time
constraints,
for
cancer
prevention.
Rice
callus
suspension
cultures
(RCSC)
seed
extracts
prepared
from
aromatic
rice
varieties
evaluated
cytotoxic
impact
on
human
colon
lung
cell
lines,
as
well
a
normal
control
line,
using
Taxol
positive
control.
RCSC
two
Indian
applied
at
different
concentrations
treat
the
lines
fibroblasts
over
varying
intervals.
Apoptosis
was
assessed
in
1:5
dilution
A549
HT-29
treated
72
h,
propidium
iodide
staining
flow
cytometry.
showed
more
potent
effect
than
minimal
contrast
Taxol.
Confocal
microscopy
cytometry
further
confirmed
apoptotic
RCSC.
Gas
chromatography-mass
spectrometry-based
metabolic
profiling
identified
metabolites
involved
cytotoxicity,
highlighted
altered
pathways.
is
proposed
an
alternative
source
development
novel
anticancer
drugs
reduced
effects.